Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.74902 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.96841 | 42 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7741 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.64692 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.62536 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.86383 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.11857 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.70506 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67576 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.62634 | 28 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.94105 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.675 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.70239 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.87444 | 38 |